Quantum BioPharma Ltd. (CSE: QNTM)

Canada flag Canada · Delayed Price · Currency is CAD
5.46
+0.21 (4.00%)
Dec 20, 2024, 10:12 AM EST
-93.44%
Market Cap 8.08M
Revenue (ttm) n/a
Net Income (ttm) -13.83M
Shares Out 1.92M
EPS (ttm) -17.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open 5.46
Previous Close 5.25
Day's Range 5.46 - 5.46
52-Week Range 4.55 - 96.20
Beta 0.82
Analysts n/a
Price Target n/a
Earnings Date Mar 7, 2025

About Quantum BioPharma

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism o... [Read more]

Sector Healthcare
CEO Zeeshan Saeed
Employees 17
Stock Exchange Canadian Securities Exchange
Ticker Symbol QNTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.